ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Kidney Transplantation Outcomes from Donors with Acute Kidney Injury.

    S. Channapatna Suresh, M. Lubetzky, J. Graham, A. Chokechanaisakul, O. Mohammed, M. Kinkhabwala, E. Akalin, J. Rocca, P. Bedi.

    Abdominal Transplant Surgery, Montefiore Medical Center, Bronx, NY

    Background- Organ scarcity and increased waiting times for kidney transplantation has led the transplant community to utilize more sub-optimal organs while continuing providing survival benefit…
  • 2017 American Transplant Congress

    Increasing Living Donation by Implementing the Kidney Coach Program.

    D. LaPointe Rudow, S. Geatrakas, J. Armenti, A. Tomback, R. Shapiro.

    Recanati Miller Transplantation Institute, Mount Sinai Hospital, New York, NY

    Introduction: It is firmly established that for patients requiring transplant, living donor kidney transplantation (LDKT) is better than deceased donor transplantation. However, recipients find it…
  • 2017 American Transplant Congress

    Pregnancy Outcomes in Female Kidney Transplant Recipients Using Assisted Fertility Methods.

    L. Coscia,1 D. Armenti,1 S. Constantinescu,1,2 M. Moritz.1,3,4

    1Transplant Pregnancy Registry, Gift of Life Institute, Philadelphia, PA; 2Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA; 3Surgery, Lehigh Valley Health Network, Allentown, PA; 4Morsani College of Medicine, USF, Tampa, FL

    The purpose of this study was to analyze pregnancy and transplant outcomes in female kidney recipients who used fertility medications alone (FM), intrauterine insemination (IUI),…
  • 2017 American Transplant Congress

    Impact of Type 2 Surgical Injuries in Postmortem Donor Kidneys on the Post-Transplant Outcomes When Compared to Mate Non-Injured Kidney from the Same Donor.

    M. Mujtaba,1 A. Gamilla-Crudo,1 K. Gugliuzza,2 O. Aleter,1 S. Shah,1 Y. Chapman,3 J. Reese,3 S. Masood,1 T. Taber.4

    1Division of Nephrology and Hypertension, University of Texas Medical Branch, Galveston, TX; 2Department of Surgery, University of Texas Medical Branch, Galveston, TX; 3Southwest Transplant Alliance, Dallas, TX; 4Division of Nephrology, Indiana University, Indianapolis, IN

    Introduction - While damage to the procured organ is rare with organ loss being approximately 0.3% of procured organs, loss of potential transplantable organs does…
  • 2017 American Transplant Congress

    Survival Benefit of Kidney and/or Pancreas Transplantation for Patients with Type 1 Diabetes in the United States.

    R. Gruessner,1 M. Laftavi,1 O. Pankowycz,2 V. Whittaker,1 Z. Acun,1 V. Aggarwal,2 N. Ozden,2 A. Gruessner.1

    1Surgery, SUNY Upstate Medical University, Syracuse, NY; 2Internal Medicine, SUNY Upstate Medical University, Syracuse, NY

    Study Purpose: The purpose of this study was to determine the survival benefit of pancreas and/or kidney transplants as reported over a 28-year time period…
  • 2017 American Transplant Congress

    CD19+CD38hiCD24hi Immature Transitional B Cells in PBMCs of Tolerant Kidney Recipients of Facilitating Cell-Enriched Hematopoietic Stem Cells and Renal Allografts.

    Y. Wen,1 A. Merchak,1 Y. Huang,1 H. Xu,1 L. Kahn,1 J. Leventhal,2 S. Ildstad.1

    1Institute for Cellular Therapeutics, University of Louisville, Louisville, KY; 2Comprehensive Transplant Center, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL

    CD19+CD38hiCD24hi immature transitional B cells may represent a biomarker for transplantation tolerance in kidney transplant (KTx) recipients (Cherukuri A, et al. J Am Soc Nephrol.…
  • 2017 American Transplant Congress

    Conversion from Tacrolimus-Based to Everolimus-Based Immunosuppressive Therapy 3 Months After Living-Donor Kidney Transplantation: A Randomized-Controlled Clinical Trial.

    D. Hesselink,1 N. Shuker,1 J. Osinga,1 M. Clahsen -van Groningen,2 J. Damman,2 C. Baan,1 J. van de Wetering,1 A. Rowshani,1 J. Kal -van Gestel,1 W. Weimar,1 T. van Gelder,3 R. Bouamar.3

    1Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; 2Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; 3Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands

    While conversion from ciclosporin to everolimus is well documented, conversion from tacrolimus has been poorly studied. In this randomized-controlled trial the safety and tolerability of…
  • 2017 American Transplant Congress

    Comparison of Long Term Renal Function Outcomes for Everolimus (EVR) vs. Sirolimus (SIR) vs. Mycophenolate Acid (MPA) Immunosuppressive Regimens Post Kidney Transplant (Ktx).

    H. Tedesco,1 W. Irish,2 K. Dharmesh,3 D. Patel,3 D. Cibrik.4

    1Hospital do Rim UNIFESP, Sao Paulo, Brazil; 2CTI Consulting, Raleigh; 3Novartis Pharmaceuticals Corporation, East Hanover; 4University of Michigan, Ann Arbor

    MPA or mammalian target of rapamycin inhibitors (mTORi [EVR or SIR]) in combination with calcineurin inhibitors (CNI, tacrolimus [TAC] or cyclosporine) are used for maintenance…
  • 2017 American Transplant Congress

    Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients.

    L. Qu, Z. Xie, H. Huang, H. Jiang, J. Chen, H. Jiang, H. Jiang, J. Chen, J. Chen, J. Chen.

    Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China

    Background The aim of the present study is to determine whether CYP3A5*A and CYP3A5*G genotype is a predictive index of tacrolimus dose requirement, and also…
  • 2017 American Transplant Congress

    Association Between Matrix-gla Protein Levels and Aortic Stiffness in Kidney Transplantation.

    M. Dinic,1 N. Maillard,1 P. Delanaye,2 J.-M. Krzesinski,2 A.-M. Saint-Remy,2 E. Cavalier,3 C. Mariat.1

    1Nephrology, Dialysis and Renal Transplantation, CHU Nord, Saint Etienne, France; 2Nephrology and Dialysis, University of Liège, CHU Sart Tilman, Liège, Belgium; 3Clinical Chemistry, University of Liège, CHU Sart Tilman, Liège, Belgium

    INTRODUCTIONAortic stiffness due to vascular calcifications is commonly observed among kidney transplant recipients and is considered as a predictive factor of poor events such as…
  • « Previous Page
  • 1
  • …
  • 373
  • 374
  • 375
  • 376
  • 377
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences